Uncategorized
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in June: Jefferies 2017 Global Healthcare ConferencePresentation: Friday, June 9, 2017 at 9:30 a.m. Eastern TimeThe Grand Hyatt New York Ho